Replagal has been approved by Health Canada as of February 2017..

Shares

Exciting news for the CFA Community – Replagal has been approved by Health Canada as of February 2017 and all patients have been transitioned from the REP-081 study at this point. Replagal is a long-term Enzyme Replacement Therapy (ERT), the infusion will be given every 2 weeks, treatment time being approximately 4o minutes. It is wonderful to have this product approved and available to Canadian patients. The delivery system will be the same, for more information click on the link to read the patient information leaflet.

http://www.shirecanada.com/-/media/shire/shireglobal/shirecanada/pdffiles/product%20information/replagal-ci-en.pdf

Close

Contact Us

If have any questions or would like to get involved, please fill in the form below.

Subscribe error, please review your email address.

Close

You're now subscribed, thank you!

Close

There was a problem with your submission. Please check the field(s) with red label below.

Close

Your message has been sent. We'll get back to you soon!

Close